This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Can Vipshop Holdings (VIPS) Pull a Surprise in Q2 Earnings?
by Zacks Equity Research
Vipshop (VIPS) has been struggling with rising promotional costs and macroeconomic slowdown in China. However, it is focused on adding younger and more Internet-savvy shoppers to its customer base.
Paylocity (PCTY) Q2 Loss Narrower than Expected, Revenues Top
by Zacks Equity Research
Paylocity's (PCTY) Q2 results benefitted from new client addition, existing client growth and additions to HCM product suite.
CA Inc (CA) Q1 Earnings and Revenues Beat, Updates FY18 View
by Zacks Equity Research
CA Inc. (CA) Q1 Earnings benefited from acquisition synergies and an increase in software fees.
Is a Surprise in Store for Workiva (WK) in Q2 Earnings?
by Zacks Equity Research
Workiva's (WK) Q2 results are likely to benefit from growing customer base of its Wdesk platform. However, intensifying competition remains a concern.
Thomson Reuters (TRI) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Thomson Reuters' (TRI) cost-containment efforts and share buyback plans are likely to positively impact its financial performance in the second quarter.
Teradata (TDC) Q2 Earnings Miss, Transition Takes a Toll
by Zacks Equity Research
Teradata Corp's (TDC) ongoing transition continues to impact its quarterly results. In addition, sluggish spending environment and increasing competition are adding to troubles.
The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger
Sizing Up the Q2 Earning Season
by Sheraz Mian
We discuss the Q2 earnings scorecard and evolving expectations for the second half of the year.
Sizing Up the Q2 Earning Season
by Sheraz Mian
We discuss the Q2 earnings scorecard and evolving expectations for the second half of the year.
Top Analyst Reports for Oracle, Pfizer & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Pfizer (PFE) and Abbott (ABT).
What's in the Cards for ServiceNow (NOW) in Q2 Earnings?
by Zacks Equity Research
ServiceNow (NOW) enjoys a dominant position in the ITSM and ITOM markets. However, stiff competition in the non-ITSM product segment remains a concern.
IBM Downgraded to Strong Sell: What's Hurting the Stock?
by Zacks Equity Research
On Jul 12, IBM Corporation (IBM) was downgraded to a Zacks Rank #5 (Strong Sell).
IBM Offers Cloud Container Service in Australia Datacenters
by Zacks Equity Research
International Business Machines Corp. (IBM) recently announced that its cloud container service is now available from its datacenters in Sydney and Melbourne.
Zacks Investment Ideas feature highlights: Micron Technology, Oracle and Applied Materials
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Micron Technology, Oracle and Applied Materials
3 XL Tech Stocks for XL Returns
by James Giaquinto
3 XL Tech Stocks for XL Returns
DXC Acquires Microsoft Dynamics 365 Integrator Tribridge
by Zacks Equity Research
DXC Technology Company (DXC), formed through the merger of Computer Sciences and the Enterprise Services business of Hewlett Packard Enterprise (HPE), made its first acquisition yesterday, buying the privately-held Tribridge company.
Apple's Tim Cook earns $145M in 2016, Tops S&P 500 CEOs
by Zacks Equity Research
Apple Inc.'s (AAPL) Chief Executive Officer (CEO) Tim Cook has been declared the highest-paid CEO in the U.S., per a Bloomberg's report of take-home pay for the top 25 S&P 500 CEOs.
Why Investors Should Buy Agilent Technologies (A) Right Now
by Zacks Equity Research
Agilent Technologies (A) is one such technology stock which has performed well so far this year and has the potential to sustain the momentum in the near term.
Why Investors Should Buy Applied Materials (AMAT) Right Now
by Zacks Equity Research
Applied Materials, Inc. (AMAT) is one such technology stock which has performed well so far this year and has the potential to carry the momentum in near term.
Why Should You Add Intuit (INTU) to Your Portfolio Right Now
by Zacks Equity Research
Here are 6 reasons which make Intuit Inc. (INTU) an attractive investment option.
Top Ranked Momentum Stocks to Buy for July 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 3rd:
Company News for June 23, 2017
by Zacks Equity Research
Companies in the News are: ORCL,SPLS,ACN,TSLA
Oracle (ORCL) Shows Strength: Stock Adds 8.6% in Session
by Zacks Equity Research
Oracle Corporation (ORCL) moved big last session, as its shares jumped almost 9% on the day.
Top Stock Reports for Oracle, Allergan & Abbott
by Brian Hamilton
Today's Research Daily features new research reports on 12 major stocks, including Oracle (ORCL), Allergan (AGN), and Abbott (ABT).
Oracle (ORCL) Beats on Q4 Earnings & Revenues, Stock Up
by Zacks Equity Research
Oracle Corporation (ORCL) reported adjusted earnings (including stock-based compensation) of 82 cents per share that comfortably beat the Zacks Consensus Estimate of 73 cents.